A detailed history of Jane Street Group, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 291,809 shares of RDY stock, worth $4.38 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
291,809
Previous 113,168 157.85%
Holding current value
$4.38 Million
Previous $8.3 Million 167.86%
% of portfolio
0.03%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$68.26 - $76.19 $12.2 Million - $13.6 Million
178,641 Added 157.85%
291,809 $22.2 Million
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $7.29 Million - $8.4 Million
108,243 Added 2197.83%
113,168 $8.3 Million
Q4 2023

Feb 14, 2024

SELL
$64.27 - $69.9 $122,691 - $133,439
-1,909 Reduced 27.93%
4,925 $342,000
Q3 2023

Nov 14, 2023

SELL
$61.9 - $72.77 $12.6 Million - $14.8 Million
-203,599 Reduced 96.75%
6,834 $456,000
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $11 Million - $13 Million
205,479 Added 4147.74%
210,433 $13.3 Million
Q1 2023

May 15, 2023

SELL
$51.63 - $56.93 $33,869 - $37,346
-656 Reduced 11.69%
4,954 $282,000
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $525,515 - $590,241
-10,274 Reduced 64.68%
5,610 $290,000
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $792,611 - $910,470
15,884 New
15,884 $831,000
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $792,611 - $910,470
15,884 New
15,884 $831,000
Q2 2022

Aug 16, 2022

SELL
$49.62 - $58.13 $254,699 - $298,381
-5,133 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$48.27 - $65.25 $94,802 - $128,151
1,964 Added 61.98%
5,133 $286,000
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $196,858 - $235,139
3,169 New
3,169 $233,000
Q4 2020

Feb 17, 2021

SELL
$62.61 - $71.29 $390,498 - $444,635
-6,237 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$51.39 - $72.41 $114,651 - $161,546
2,231 Added 55.69%
6,237 $434,000
Q2 2020

Aug 17, 2020

BUY
$39.55 - $54.65 $158,437 - $218,927
4,006 New
4,006 $212,000
Q4 2019

Feb 14, 2020

SELL
$36.66 - $41.78 $193,894 - $220,974
-5,289 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$34.82 - $39.26 $81,931 - $92,378
-2,353 Reduced 30.79%
5,289 $200,000
Q2 2019

Aug 15, 2019

BUY
$36.05 - $42.76 $275,494 - $326,771
7,642 New
7,642 $283,000
Q4 2018

Feb 15, 2019

SELL
$31.89 - $38.44 $542,448 - $653,864
-17,010 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$29.25 - $36.73 $3.44 Million - $4.32 Million
-117,518 Reduced 87.36%
17,010 $589,000
Q2 2018

Aug 15, 2018

BUY
$28.49 - $35.06 $3.83 Million - $4.72 Million
134,528 New
134,528 $4.33 Million
Q1 2018

May 15, 2018

SELL
$31.93 - $39.54 $1.67 Million - $2.07 Million
-52,280 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$34.15 - $37.62 $1.8 Million - $1.98 Million
-52,619 Reduced 50.16%
52,280 $1.96 Million
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $3.16 Million - $3.96 Million
104,899
104,899 $3.74 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.49B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.